A Phase II Study Of Perifosine (D-21266) In Patients With Previously Untreated Metastatic Or Locally Advanced Soft Tissue Sarcoma.
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2016
At a glance
- Drugs Perifosine (Primary)
- Indications Leiomyosarcoma; Liposarcoma; Rhabdomyosarcoma; Sarcoma; Soft tissue sarcoma; Synovial sarcoma
- Focus Adverse reactions; Therapeutic Use
- 30 Jun 2010 Last checked against National Cancer Institute of Canada.
- 11 Aug 2009 Lead trial centre and lead investigators added as reported by ClinicalTrials.gov.
- 21 Mar 2006 Status changed from suspended to completed.